The global pneumonia therapeutics market is expected to reach USD 22.9 billion by 2025, according to a new report by Grand View Research, Inc. This market is anticipated to grow at an unprecedented rate owing to the increasing prevalence of pneumococcal disease globally. The increasing demand for pneumonia therapeutics is a result of unmet clinical needs in emerging as well as developed regions. Increasing focus of healthcare organizations on raising awareness and issuing guidelines for efficient management of pneumococcal disease is predicted to broaden the scope for growth over the coming years.For instance, Infectious Diseases Society of America/American Thoracic Society has issued guidelines on the management of community-acquired pneumonia. According to a white paper released by American Academy of Family Physicians, adherence to these guidelines has resulted in positive patient outcomes during the treatment of community-acquired bacterial pneumonia in patients.
Moreover,
growing R&D activities in life sciences are anticipated to create positive
impact on the market over the coming years. Consequentially, increase in number
of products, currently being reviewed under clinical trials, is anticipated to
fuel the overall growth.In the present scenario, there are 12 drugs under
investigation in phase III trials, 4 drugs under phase II, and 3 drugs under
phase I trial. The aforementioned factors exemplify the consistent efforts
being made by the market players. For instance, Omadacycline, a tetracycline
under phase III clinical trial, developed by Paratek Pharmaceuticals is being
investigated for use in the treatment of ventilator-associated and
community-acquired bacterial pneumonia.
For Full Research Report On Pneumonia Therapeutics Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/pneumonia-market
Further Key
Findings From the Report Suggest:
- Vaccines accounted for the
largest share in the product segment in 2016. This can be attributed to
their high efficacy and growing inclination of patients toward preventive
measures
- They are also expected to
grow at a lucrative rate owing to the recommendation by WHO for their
inclusion in national immunization programs
- Drugs are expected to
witness moderate growth rate throughout the forecast period. This is
believed to be a result of the infiltration of generic drugs that are more
cost-efficient.
- North America accounted fora
substantial share in the market owing toincreasing number of supportive
government initiatives and high awareness levels amongst the end-users
- Asia Pacific is expected to
witness exponential CAGR during the forecast period owing to its high
disease burden and continual infrastructural upgradation of research &
manufacturing facilities in the region
- High competition has been
observed in the market, where major players adopt strategies such as new
product development, collaborations,and strategic agreements to gain
market share
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/pneumonia-market/request/rs1
Grand View Research has segmented
the global pneumonia therapeutics market on the basis of product and region:
Pneumonia
Therapeutics Product Outlook (Revenue, USD Million, 2014 - 2025)
- Drugs
- Branded
- Quinolones
- Aminopenicillins
- Macrolides
- B-lactamase Inhibitors
- Cephalosporins
- Tetracyclines
- Glycopeptide Antibiotics
- Carbapenems
- Others
- Generics
- Quinolones
- Macrolides
- Others
- Vaccines
- Oxygen Therapy
Pneumonia
Therapeutics Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia Pacific
- Japan
- China
- India
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- South Africa
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment